<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: centers for medicare medicaid</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'centers for medicare medicaid'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22centers+for+medicare+medicaid%22&t=%22centers+for+medicare+medicaid%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:59:52 +0100</lastBuildDate>
        <item>
            <title>Balancing Access to Experts and Better Pay for Primary Care</title>
            <link>http://www.medworm.com/index.php?rid=3208364&amp;cid=t_155788_87_f&amp;fid=38368&amp;url=http%3A%2F%2Fedocket.access.gpo.gov%2F2009%2Fpdf%2FE9-26502.pdf</link>
            <description>Every January, new billing rules and rates go into place for physicians’ services as part of the annual update to Medicare’s Physician Fee Schedule. Dominating DC health policy concerns in this arena are the medical community’s efforts with Congress to address Medicare’s cost-of-living adjuster, known as the “sustainable growth rate” (SGR), which would have lowered 2010 fees across-the-board by 21 percent, if not for a last-minute temporary stay through the end of February. Negotiations with Congress are on-going to provide a long term or multi-year solution—a costly “fix” that I believe is well worth the price to keep physicians in the Medicare program, and seems to have widespread support.
Getting much less attention is a unilateral policy pronouncement made by the Cent...</description>
            <author>Disruptive Women in Health Care</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3208364</comments>
            <pubDate>Tue, 26 Jan 2010 13:00:43 +0100</pubDate>
            <guid isPermaLink="false">3208364</guid>        </item>
        <item>
            <title>Medicare Expands Coverage of PET Scans as Cancer Diagnostic Tool</title>
            <link>http://www.medworm.com/index.php?rid=2326618&amp;cid=t_155788_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2009%2F04%2F07%2Fmedicare-expands-coverage-of-pet-scans-as-cancer-diagnostic-tool%2F</link>
            <description>&amp;#8220;The Centers for Medicare &amp;#38; Medicaid Services (CMS) issued a final national coverage determination (NCD) to expand coverage for initial testing with positron emission tomography (PET) for Medicare beneficiaries who are diagnosed with and treated for most solid tumor cancers.  This decision applies to PET scans used to support initial diagnosis and treatment for most [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2326618</comments>
            <pubDate>Tue, 07 Apr 2009 21:36:08 +0100</pubDate>
            <guid isPermaLink="false">2326618</guid>        </item>
        <item>
            <title>Senators Kennedy &amp; Hutchison Renew War On Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2299061&amp;cid=t_155788_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2009%2F03%2F30%2Fsenators-kennedy-hutchison-renew-war-on-cancer%2F</link>
            <description>On March 26, 2009, Senators Edward M. Kennedy (D-Massachusetts) and Kay Bailey Hutchison (R-Texas) introduced the 21st Century Cancer Access to Life-Saving Early detection, Research and Treatment (ALERT) Act, a bill to comprehensively address the challenges our nation faces in battling cancer. This is the first sweeping cancer legislation introduced since the National Cancer Act [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2299061</comments>
            <pubDate>Tue, 31 Mar 2009 05:32:52 +0100</pubDate>
            <guid isPermaLink="false">2299061</guid>        </item>
        <item>
            <title>Amgen Revises EPO Labels, But Petitions Medicare</title>
            <link>http://www.medworm.com/index.php?rid=1015066&amp;cid=t_155788_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F181677360%2F</link>
            <description>The biotech made several changes to the warning labels on its EPO drugs, Aranesp and Epogen, and six new clinical trials are being proposed to assess their safety in treating chemotherapy-induced anemia in specific types of tumors. The revised labels say therapy should end following the completion of chemotherapy, and patient dosing should be adjusted to achieve and maintain the lowest hemoglobin level possible to avoid a blood transfusion. The warnings also state that the hemoglobin level should not exceed the upper safety limit of 12 grams per deciliter of blood.
The changes to the boxed warnings include additional language in the indications and usage section, addition of an oncology study to the warnings section, and clarification of the hemoglobin range for chronic renal failure patie...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1015066</comments>
            <pubDate>Thu, 08 Nov 2007 15:13:10 +0100</pubDate>
            <guid isPermaLink="false">1015066</guid>        </item>
    </channel>
</rss>

